DMAAU P/E Ratio
P/E Ratio as of Oct 13, 2025: 106.82
Average106.77
Median107.00
Minimum105.49
Maximum107.83
106.82
Past Month-1.01 (0.94%)
The P/E ratio for DMAAU is 106.82 as of Oct 13, 2025. This represents a increase of 298.73% compared to its 12-month average P/E ratio of 26.79. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Drugs Made In America Acquisition Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Drugs Made In America Acquisition Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Drugs Made In America Acquisition Corp to industry peers.
Drugs Made In America Acquisition Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Drugs Made In America Acquisition Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Drugs Made In America Acquisition Corp to industry peers.
DMAAU P/E Ratio Insights
See Drugs Made In America Acquisition Corp’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in DMAAU
Order type
Buy in
Order amount
Est. shares
0 shares
DMAAU P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2025 | $10.40 | 105.80 |
| Sep 2, 2025 | — | 107.83 |
| Aug 25, 2025 | $10.60 | 107.83 |
DMAAU End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | 106.82 | — |
FAQs About Drugs Made In America Acquisition Corp (DMAAU) P/E ratio
The latest P/E ratio of DMAAU is 106.82, as of Oct 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Drugs Made In America Acquisition Corp’s last 12-month average P/E ratio is 26.79, compared to its current P/E ratio of 106.82. This reflects a increase of 298.73%.
Drugs Made In America Acquisition Corp’s current P/E ratio of 106.82 is higher than its last 12-month average P/E of 26.79. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Drugs Made In America Acquisition Corp’s average P/E ratio over the last 3 years is 8.93. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Drugs Made In America Acquisition Corp’s average P/E ratio over the last 5 years is 5.36. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.